Assignee
DELTA FLY PHARMA INC
JP·11 granted patents·3 pending applications·6 citations·filing 2010–2021
Top patents by PatentIndex Score
14 records- 0184US10111955B2PEG derivativeDELTA FLY PHARMA INC·Filed 2015·Granted Oct 30, 2018·3 cites·8 claims
- 0271US9855345B2Method for producing lipoplex for topical administration and antitumor agent using such lipoplexDELTA-FLY PHARMA INC·Filed 2015·Granted Jan 2, 2018·1 cites·4 claims
- 0369US10293019B2Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patientDELTA FLY PHARMA INC·Filed 2015·Granted May 21, 2019·1 cites·2 claims
- 0463US9745583B2Liposome for topical administration and application thereofDELTA-FLY PHARMA INC·Filed 2013·Granted Aug 29, 2017·1 cites·15 claims
- 0560US11185517B2Pharmaceutical composition for treatment or remission of chronic myelogenous leukemiaDELTA FLY PHARMA INC·Filed 2019·Granted Nov 30, 2021·0 cites·6 claims
- 0656US11246847B2Anticancer drug effect enhancerDELTA FLY PHARMA INC·Filed 2020·Granted Feb 15, 2022·0 cites·20 claims
- 0755US11957701B2Therapy and new therapeutic agent for blood cancerDELTA FLY PHARMA INC·Filed 2020·Granted Apr 16, 2024·0 cites·8 claims
- 0855US11524078B2Water-soluble macromolecular derivative of VenetoclaxDELTA FLY PHARMA INC·Filed 2020·Granted Dec 13, 2022·0 cites·4 claims
- 0952US11684582B2Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereofDELTA FLY PHARMA INC·Filed 2021·Granted Jun 27, 2023·0 cites·11 claims
- 1051US2024238293A1Combined pharmaceutical preparation for treating a terminal non-small cell lung cancer patient with brain metastasisDELTA FLY PHARMA INC·Filed 2020·Application pending·0 cites
- 1149US2019247338A1Pharmaceutical composition for treatment or remission of chronic myelogenous leukemiaDELTA FLY PHARMA INC·Filed 2017·Application pending·0 cites
- 1245US11622976B2Urine alkali agent useful for treatment of cancer patientDELTA FLY PHARMA INC·Filed 2018·Granted Apr 11, 2023·0 cites·24 claims
- 1336US2020138855A1Novel antineoplastic drug based on specificity of cancer-cell metabolismDELTA FLY PHARMA INC·Filed 2017·Application pending·0 cites
- 1435US8377905B2Stable crystal of 1-(2′-cyano-2′-deoxy-β-D-arabinofuranosyl)cytosine monohydrochlorideDELTA FLY PHARMA INC·Filed 2010·Granted Feb 19, 2013·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when DELTA FLY PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →